Long-term survival achieved in metastatic melanoma with personalized vaccine

Posted by on May 10, 2016 8:51 pm
Categories: health

Two patients with melanoma that had spread to the liver survived for at least 8.5 and 12 years after resection of the hepatic tumor and treatment with patient-specific immunotherapeutic vaccines. The vaccines, designed to activate the immune system against the tumor, were derived from the patients’ own dendritic cells loaded with proteins isolated from their tumors.

Leave a Reply

Your email address will not be published. Required fields are marked *